273 related articles for article (PubMed ID: 9815266)
1. Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis.
Olivares-Villagómez D; Wang Y; Lafaille JJ
J Exp Med; 1998 Nov; 188(10):1883-94. PubMed ID: 9815266
[TBL] [Abstract][Full Text] [Related]
2. CD4(+) T cells prevent spontaneous experimental autoimmune encephalomyelitis in anti-myelin basic protein T cell receptor transgenic mice.
Van de Keere F; Tonegawa S
J Exp Med; 1998 Nov; 188(10):1875-82. PubMed ID: 9815265
[TBL] [Abstract][Full Text] [Related]
3. Endogenous CD4+BV8S2- T cells from TG BV8S2+ donors confer complete protection against spontaneous experimental encephalomyelitis (Sp-EAE) in TCR transgenic, RAG-/- mice.
Matejuk A; Buenafe AC; Dwyer J; Ito A; Silverman M; Zamora A; Subramanian S; Vandenbark AA; Offner H
J Neurosci Res; 2003 Jan; 71(1):89-103. PubMed ID: 12478617
[TBL] [Abstract][Full Text] [Related]
4. Specificity requirements for selection and effector functions of CD25+4+ regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice.
Hori S; Haury M; Coutinho A; Demengeot J
Proc Natl Acad Sci U S A; 2002 Jun; 99(12):8213-8. PubMed ID: 12034883
[TBL] [Abstract][Full Text] [Related]
5. High incidence of spontaneous autoimmune encephalomyelitis in immunodeficient anti-myelin basic protein T cell receptor transgenic mice.
Lafaille JJ; Nagashima K; Katsuki M; Tonegawa S
Cell; 1994 Aug; 78(3):399-408. PubMed ID: 7520367
[TBL] [Abstract][Full Text] [Related]
6. Repertoire requirements of CD4+ T cells that prevent spontaneous autoimmune encephalomyelitis.
Olivares-Villagómez D; Wensky AK; Wang Y; Lafaille JJ
J Immunol; 2000 May; 164(10):5499-507. PubMed ID: 10799918
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).
Kumar V; Stellrecht K; Sercarz E
J Exp Med; 1996 Nov; 184(5):1609-17. PubMed ID: 8920851
[TBL] [Abstract][Full Text] [Related]
8. The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease.
Kumar V; Sercarz EE
J Exp Med; 1993 Sep; 178(3):909-16. PubMed ID: 7688792
[TBL] [Abstract][Full Text] [Related]
9. Regulatory T cells in spontaneous autoimmune encephalomyelitis.
Furtado GC; Olivares-Villagómez D; Curotto de Lafaille MA; Wensky AK; Latkowski JA; Lafaille JJ
Immunol Rev; 2001 Aug; 182():122-34. PubMed ID: 11722629
[TBL] [Abstract][Full Text] [Related]
10. Endogenous T Cell Receptor Rearrangement Represses Aggressive Central Nervous System Autoimmunity in a TcR-Transgenic Model on the Non-Obese Diabetic Background.
Yeola AP; Ignatius Arokia Doss PM; Baillargeon J; Akbar I; Mailhot B; Balood M; Talbot S; Anderson AC; Lacroix S; Rangachari M
Front Immunol; 2019; 10():3115. PubMed ID: 32010149
[TBL] [Abstract][Full Text] [Related]
11. HLA-DR4-IE chimeric class II transgenic, murine class II-deficient mice are susceptible to experimental allergic encephalomyelitis.
Ito K; Bian HJ; Molina M; Han J; Magram J; Saar E; Belunis C; Bolin DR; Arceo R; Campbell R; Falcioni F; Vidović D; Hammer J; Nagy ZA
J Exp Med; 1996 Jun; 183(6):2635-44. PubMed ID: 8676084
[TBL] [Abstract][Full Text] [Related]
12. Oral tolerance in myelin basic protein T-cell receptor transgenic mice: suppression of autoimmune encephalomyelitis and dose-dependent induction of regulatory cells.
Chen Y; Inobe J; Kuchroo VK; Baron JL; Janeway CA; Weiner HL
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):388-91. PubMed ID: 8552644
[TBL] [Abstract][Full Text] [Related]
13. IFN-gamma determines distinct clinical outcomes in autoimmune encephalomyelitis.
Wensky AK; Furtado GC; Marcondes MC; Chen S; Manfra D; Lira SA; Zagzag D; Lafaille JJ
J Immunol; 2005 Feb; 174(3):1416-23. PubMed ID: 15661899
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of recovery from experimental autoimmune encephalomyelitis: T cell deletion and immune deviation in myelin basic protein T cell receptor transgenic mice.
Chen Y; Hancock WW; Marks R; Gonnella P; Weiner HL
J Neuroimmunol; 1998 Mar; 82(2):149-59. PubMed ID: 9585811
[TBL] [Abstract][Full Text] [Related]
15. Experimental autoimmune encephalomyelitis-resistant mice have highly encephalitogenic myelin basic protein (MBP)-specific T cell clones that recognize a MBP peptide with high affinity for MHC class II.
Abromson-Leeman S; Alexander J; Bronson R; Carroll J; Southwood S; Dorf M
J Immunol; 1995 Jan; 154(1):388-98. PubMed ID: 7527816
[TBL] [Abstract][Full Text] [Related]
16. Experimental autoimmune encephalomyelitis in mice expressing the autoantigen MBP 1-10 covalently bound to the MHC class II molecule I-Au.
Kurschus FC; Oelert T; Liliensiek B; Buchmann P; Wraith DC; Hämmerling GJ; Arnold B
Int Immunol; 2006 Jan; 18(1):151-62. PubMed ID: 16361316
[TBL] [Abstract][Full Text] [Related]
17. Experimental allergic encephalomyelitis in susceptible and resistant strains of mice after adoptive transfer of T cells activated by antibodies to the T cell receptor complex.
Zhao ML; Xia JQ; Fritz RB
J Neuroimmunol; 1992 Sep; 40(1):31-9. PubMed ID: 1381381
[TBL] [Abstract][Full Text] [Related]
18. Engineered MBP-specific human Tregs ameliorate MOG-induced EAE through IL-2-triggered inhibition of effector T cells.
Kim YC; Zhang AH; Yoon J; Culp WE; Lees JR; Wucherpfennig KW; Scott DW
J Autoimmun; 2018 Aug; 92():77-86. PubMed ID: 29857928
[TBL] [Abstract][Full Text] [Related]
19. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10.
Burkhart C; Liu GY; Anderton SM; Metzler B; Wraith DC
Int Immunol; 1999 Oct; 11(10):1625-34. PubMed ID: 10508180
[TBL] [Abstract][Full Text] [Related]
20. CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis.
Grewal IS; Foellmer HG; Grewal KD; Wang H; Lee WP; Tumas D; Janeway CA; Flavell RA
Immunity; 2001 Mar; 14(3):291-302. PubMed ID: 11290338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]